VLA 0.00% $1.75 viralytics limited

Think before you act, page-26

  1. 528 Posts.
    lightbulb Created with Sketch. 36
    I don't think much of the IDO1 inhibitor in comparison to Cavatak. However I will look at those results more thoroughly.

    Cavatak is (now) a targeting mechanism, while the checkpoint-inhibitor super charges the immune response (inhibits the automatic down-regulators abused by tumours under attack).

    IDO1 inhibitor plus another checkpoint-inhibitor is less exciting to me.
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.